A multicenter, double-blind, placebo-controlled, dose-ranging study to assess the efficacy and safety of doxercalciferol capsules in the treatment of subjects with moderate to severe chronic plaque psoriasis.
Phase of Trial: Phase II
Latest Information Update: 19 Jun 2014
At a glance
- Drugs Doxercalciferol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Sanofi
- 03 May 2014 The number of treatment arms have been changed from 2 to 4 and drug dosages have been added as reported by ClinicalTrials.gov record.
- 08 Oct 2009 New trial record.